Why Parents Hesitate Before Seeking Mental-Health Expertise
Parents who have no problem making a doctor's appointment when their children have a cough, sneeze, or sniffle appear to be resistant when it comes to mental health.
Parents Magazine and the Child Mind Institute conducted a new survey to find out why parents hesitate before getting mental-health expertise for their children.
"If your child has a fever you take them to the doctor, if your child has an emotional pain, it should be the same thing," said Liz Vaccariello, the editor-in-chief of Parents Magazine, in an interview with Cheddar on Tuesday.
A new survey of about 400 parents in the United States found 62% would wait more than five weeks to get their children help with a mood or behavior disorder.
Of the families that said they would think twice before pursuing treatment options, most (83%) said they try to avoid an overreaction and would rather wait to see if symptoms resolve on their own. Other reasons include the perceived cost of mental-health care and the fear that their children would be labelled mentally ill.
"All of these are myths and we're trying to overcome that," said Vaccariello.
She said parents should be vigilant about monitoring their children's behavior for potential warning signs. Doctors describe these potential symptoms as "pink flags" instead of "red flags" because they're often subtle indicators of mental illness.
Vaccariello said symptoms include sleep disturbances, obsessive thoughts, and debilitating fears.
"It's one thing to be scared of a bee, it's another thing to be terrified to go outside because you don't want to be stung by a bee," she said.
There are fewer than 9,000 clinical child psychiatrists in the United States, but Vaccariello said parents can also reach out to child psychologists, therapists, and school counselors.
"Even something like that can be helpful and healing for the whole family," she said.
For full interview, [click here](https://cheddar.com/videos/why-do-parents-wait-to-seek-help-on-mental-health-issues).
Dr. Farhan Bhatti, a family physician and Michigan State lead for the Committee to Protect Health Care, joined Cheddar to discuss the newly discovered and highly transmissible omicron variant of COVID-19. Bhatti said it is too early to draw any conclusions about the new variant but there is concern that it could eventually mutate and develop a resistance to vaccines. "Time will tell, but for now, it looks like, still, the best thing that we can do to try to limit the spread of this disease is make sure everybody gets a vaccine and make sure everybody avoids large gatherings indoors and wears masks during the wintertime especially," he said.
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
A CDC panel unanimously endorsed Moderna and Pfizer Covid-19 vaccine boosters for all U.S. adults. This comes after the FDA gave its own authorization for everyone 18 and older, scrapping previous eligibility factors like age and underlying conditions. Dr. Shereef Elnahal, President and CEO of University Hospital and former New Jersey Health Commissioner, joined Cheddar News to break down the development.
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
Dr. David Dodson, Infectious Disease Specialist at Carden & Dodson MD, joined Wake Up With Cheddar to break down what we know so far about the Omicron Covid-19 variant, and why you shouldn't wait for an Omicron-specific shot to get vaccinated.
Friday saw big sell offs, with the Dow Jones posting its worst day since October 2020, falling 905 points, with the Nasdaq and S&P 500 each tumbling more than two percent as well. Much of that due to investor concerns over the new Covid-19 'Omicron' variant first detected in South Africa. Craig Erlam, senior market analyst at Oanda explains what investors should expect this week.
The ocean is an important topic when it comes to the climate. It plays a vital role in shaping our environment, with rising sea levels causing a 35% increase in natural disasters around the world, affecting 1.7 billion people. Dr. Sylvia Earle has been called perhaps the greatest advocate our oceans have ever had, with Time magazine dubbing her its first 'hero of the planet' and the Library of Congress naming her a living legend. She is also the founder of Mission Blue, an organization that inspires action to explore and protect the ocean. Dr. Earle joined Cheddar Climate for more on the importance of caring for the ocean and its impact on climate change.
Scientists are racing to understand the Omicron variant of covid-19 and find out just how dangerous it really is. Omicron, dubbed a variant of concern by the WHO, was first detected in South Africa last week and has already spread to multiple countries, including the UK, Canada, Australia and more. Dr. Jonathan Javitt, CEO of Nrx and adjunct professor at Johns Hopkins School of Medicine, joined Cheddar to discuss what we know and don't know about this new variant.
The House has officially passed the $1.75 trillion social policy and climate big. This new bill is expected to bring some huge investments into working towards fighting climate change. U.S. President of We Don't Have Time, Sweta Chakraborty, joined Cheddar to discuss more.
